Shares of Applied DNA Sciences APDN fell 7.8% in after-market trading after the company reported Q3 results.
Quarterly Results
Earnings per share rose 36.11% year over year to ($0.46), which missed the estimate of ($0.22).
Revenue of $1,700,000 rose by 293.96% year over year, which missed the estimate of $3,130,000.
Looking Ahead
Applied DNA Sciences hasn't issued any earnings guidance for the time being.
Revenue guidance hasn't been issued by the company for now.
Conference Call Details
Date: Aug 12, 2021
Time: 04:30 PM
ET Webcast URL: https://services.choruscall.com/mediaframe/webcast.html?webcastid=Bin1qa3n
Price Action
Company's 52-week high was at $13.64
52-week low: $4.95
Price action over last quarter: down 1.78%
Company Overview
Applied DNA Sciences Inc is a provider of DNA-based supply chain, anti-counterfeiting, and anti-theft technology. The company provides its products and services under the brand of SigNature DNA, SigNature T DNA, fiberTyping, DNAnet, digitalDNA, SigNify and Beacon. It serves clients in various industries including government/military, security and asset marking, industrial parts, pharmaceuticals, textiles and apparel, and printing and packaging. The company has operational footprints across the United States, Europe, Asia, and others.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Date | ticker | name | Actual EPS | EPS Surprise | Actual Rev | Rev Surprise |
|---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
